Clinical Trials

It is important to take part in clinical trials if you can. Often, there are opportunities for family members who do not have Parkinson’s disease to also help advance research for therapies and a cure.

Clinical trial information is submitted to the Parkinson Support Center of Kentuckiana by partner research institutions and pharma/device companies. Be an informed participant!

Research Subjects Needed

 

Submitted by: Sunovion Pharmaceuticals  SEP 361-203
SEP-363856 for Parkinson’s Psychosis

What: The SEP361-203 study will evaluate if an investigational drug (SEP-363856) is safe and effective in patients that have Parkinson’s disease with symptoms of hallucinations and/or delusions

Who: The study is looking for men and post-menopausal women over age 55 with Parkinson’s psychosis who have a care partner who can also attend all study visits

Where: This study is taking place at about 12 sites across the United States.

To learn more about the SEP361-203 study, view study site locations, and see if you may be eligible visit www.pdpclinicaltrial.com.

Supporting Documents
SUNOVION SEP361-203_IRB Patient Brochure_Poster_
SEP361-203 Study Patient Brochure_V02USA

 

Submitted by: The UofL Parkinson’s and Movement Disorder Center
Subcutaneous Levodopa Infusion Study ABBV-951

What: The UofL Parkinson’s and Movement Disorder Center is recruiting for an open-label study in subjects with Parkinson’s Disease to evaluate the safety and tolerability of titration and continuous subcutaneous infusion of ABBV-951 for up to 4 weeks. The study is testing subcutaneous administration of levodopa for patients with motor fluctuations. It will deliver levodopa through a continuous infusion pump that is worn daily.

Who: Patients between ages 30-85 may qualify.

Where: Contact Annette Robinson at 502-540-3585 or annette.robinson@louisville.edu.

 

Submitted by: The UofL Parkinson’s and Movement Disorder Center
Spire Study

What: The UofL Parkinson’s and Movement Disorder Center is recruiting for a study in subjects with Parkinson’s Disease to determine if mindfulness and attention to breathing can improve anxiety symptoms in people with Parkinson’s disease for up to 6 weeks. This study will use the commercially available Spire activity tracker that can be worn on clothing and is used to track breathing rate and activity throughout the day. At the end of the study, participants will be able to keep the tracker for personal use.

Who: Patients between ages 40-80, currently experiencing anxiety may qualify

Where: This study is taking place at two sites – University of Louisville and University of Cincinnati

To learn more about the Spire study, contact Anushree Lingaiah at 502-582-7654 or anushree.lingaiah@louisville.edu

Supporting Documents
Science Behind Spire
Spire User Guide Stamped Filed
IRB Spire Study Recruitment Flyer Nov 18

 

Submitted by: The UofL Parkinson’s and Movement Disorder Center and the UofL Gynecology Clinic
Survey of Pelvic Floor complaints in women with Parkinson’s Disease

What: This survey intends to study the prevalence of pelvic floor in women with idiopathic Parkinson’s disease. Urinary symptoms commonly present as non-motor symptoms, and can significantly impact quality of life.

Who: Women between ages 40 to 85 with idiopathic Parkinson’s disease can participate in this study

Where: ULP Movement Disorders Clinic at Frazier Rehab Institute

To learn more, contact Diksha Mohanty at 502-582-7654 or diksha.mohanty@louisville.edu

Supporting Documents
PFD PD flyer final